Target intelligence / Profile preview

SNTG2 antisense RNA 1 (SNTG2-AS1)

Target: SNTG2-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

SNTG2 Antisense RNA 1 (SNTG2-AS1) is an antisense long non-coding RNA (lncRNA) gene that resides near and is transcribed in the opposite direction of the SNTG2 gene, which codes for syntrophin gamma 2[6]. While many antisense lncRNAs regulate their host gene, the specific function of SNTG2-AS1 remains unknown and unstudied. There is no direct evidence suggesting it plays a role in disease, serves as a therapeutic target, interacts with drugs, or acts as a clinical biomarker. The biological relevance of SNTG2-AS1 may be mediated through regulatory effects on SNTG2, but further research is needed to establish its function[6][4]. If more information or functional research emerges, additional annotations may be required; but as of now, SNTG2-AS1 is best classified as a non-coding antisense transcript with unknown regulatory and disease associations[4][6].

Other names: SNTG2-AS1SNTG2 antisense RNA 1

Biological functions

Unknown (possible regulation of the nearby SNTG2 gene via antisense mechanisms, but not directly established)

Disease associations

None established (no direct role in disease reported; nearby SNTG2 duplication observed in schizophrenia patients, but SNTG2-AS1 itself is not implicated)

Beyond the preview

Go deeper on SNTG2 antisense RNA 1 (SNTG2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNTG2 antisense RNA 1 (SNTG2-AS1).

Explore the full profile